Median Survival Rate Nearly Doubles Combining Inotuzumab with Chemotherapy

Cancer-News has 181 videos Subscribe Here

Description: Hagop M. Kantarjian, MD of MD Anderson Cancer Center's Department of Leukemia states the
median survival rate nearly doubles combining Inotuzumab with chemotherapy for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia.
Shared By : Cancer-News
Posted on : 08/30/17
Added : 2 years ago